Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310

Next Previous
Search
Trial Profile

Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 11 Dec 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Treprostinil (Primary)
  • Indications Pulmonary arterial hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors United Therapeutics Corporation

    • Most Recent Events

    • 06 Dec 2023 Results of three additional years of open-label observation after the close of the placebo-controlled, event-driven study, associated with improved survival in FREEDOM-EV and its Open-Label Extension published in the Advances in Therapy
    • 19 Oct 2022 Results assessing efficacy of treprostinil in pulmonary arterial hypertension participants in Freedom-Ev (NCT01560624) and the Freedom-Ev Open-Label Extension (OLE, NCT01560637) studies, presented at the CHEST Annual Meeting 2022 by Annual Meeting of the American College of Chest Physicians.
    • 14 Oct 2022 According to a United Therapeutics Corporation media release, long-term data from this trial will be presented at the CHEST 2022 Annual Meeting hosted by the American College of Chest Physicians.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top